Amgen (AMGN) FY2015 results: revenue $21.7 billion, up 8.0% on the year
Amgen Inc. (AMGN) reported revenue of $21.7 billion for fiscal 2015, the year ended 31 December 2015, up 8.0% on the year before. Net income was $6.9 billion, up 34.5%, and diluted earnings per share $9.06. The figures are the company's own, from the 10-K it filed with the SEC on 16 February 2016.
Revenue
$21.7 billion
+8.0% on the year
FY2008FY2015
Operating margin
39.1%
30.9% a year earlier
FY2008FY2015
Net income
$6.9 billion
+34.5% on the year
FY2008FY2015
Diluted EPS
$9.06
+35.2% on the year
FY2008FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
21,662
20,063
18,676
+8.0%
Cost of revenue
4,227
4,422
3,346
-4.4%
Gross profit
17,435
15,641
15,330
+11.5%
Gross margin
80.5%
78.0%
82.1%
Research and development
4,070
4,297
4,083
-5.3%
Selling, general and administrative
4,846
4,699
5,184
+3.1%
Operating income
8,470
6,191
5,867
+36.8%
Operating margin
39.1%
30.9%
31.4%
Interest expense
1,095
1,071
1,022
+2.2%
Pre-tax income
7,978
5,585
5,265
+42.8%
Income tax
1,039
427
184
+143.3%
Effective tax rate
13.0%
7.6%
3.5%
Net income
6,939
5,158
5,081
+34.5%
Net margin
32.0%
25.7%
27.2%
Diluted EPS
$9.06
$6.70
$6.64
+35.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
9,731
8,952
6,526
+8.7%
Capital expenditure
594
718
693
-17.3%
Free cash flow
9,137
8,234
5,833
+11.0%
Free cash flow margin
42.2%
41.0%
31.2%
Cash from investing
-5,547
-5,752
-8,469
Cash from financing
-3,771
-3,274
2,491
Depreciation and amortisation
2,108
2,092
1,286
+0.8%
Share-based compensation
322
408
403
-21.1%
Buybacks
1,867
138
832
+1,252.9%
Dividends paid
2,396
1,851
1,415
+29.4%
Diluted shares, weighted
766m
770m
765m
-0.5%
Shares outstanding at period end
754m
760m
755m
-0.8%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
28,083
25,778
22,096
+8.9%
Debt
31,429
30,588
32,128
+2.7%
Other liabilities
12,064
12,643
11,901
-4.6%
Total liabilities and equity
71,576
69,009
66,125
+3.7%
Fixed assets
4,907
5,223
5,349
-6.1%
Goodwill
14,751
14,788
14,968
-0.3%
Intangible assets
11,641
12,693
13,262
-8.3%
Investments
27,238
23,295
15,596
+16.9%
Cash and equivalents
4,144
3,731
3,805
+11.1%
Receivables
2,995
2,546
2,697
+17.6%
Inventory
2,435
2,647
3,019
-8.0%
Other assets
3,465
4,086
7,429
-15.2%
Total assets
71,576
69,009
66,125
+3.7%
10-K for the year ended 31 December 2015, filed 16 February 2016: the filing.